The CRISPR patent battle heats up with claims of misconduct

Sharon Begley, STAT News 17 August 2016

A former visiting student, Shuailiang Lin, in Feng Zhang’s lab is claiming that the Zhang lab was unable to program the CRISPR/Cas9 system until after Doudna’s 2012 Science paper.  Lin has offered his laboratory notebooks as evidence. These claims are refuted by the Broad Institute.  Emails between Doudna and Lin as well as an exchange between Lin and Zhang have been entered as evidence in the ongoing interference proceeding.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply